Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2001 of 6351
-
New drug combo aims to tame deadly transplant complication
Disease control CompletedThis phase IIa trial studies the side effects of itacitinib when given together with standard treatment (tacrolimus and sirolimus), and to see how well it works in preventing graft-versus-host-disease (GVHD) in patients with acute leukemia, myelodysplastic syndrome or myelofibros…
Phase 2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New hope for Hard-to-Treat myeloma: first human trial of forimtamig begins
Disease control CompletedThis is a first-in-human, open-label, uncontrolled, multi-center, monotherapy, dose-escalation and dose expansion study. Forimtamig will be administered to participants with r/r MM for whom no standard-of-care treatment exists or who are intolerant to those established therapies.…
Phase 1 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Tailor-Made vaccine takes on advanced melanoma in early trial
Disease control OngoingThis research study is investigating a new type of personalized neoantigen vaccine, NeoVax, plus Montanide® in combination with Ipilimumab (Yervoy™) and Nivolumab (Opdivo®) as a possible treatment for cutaneous melanoma. The drugs involved in this study are: * Personalized Neoa…
Phase 1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Face-Down therapy could save COVID patients who refuse ventilators
Symptom relief CompletedThe purpose of this trial is to determine whether Prone Positioning (PP) improves outcomes for non-intubated hospitalized patients with hypoxemic respiratory failure due to COVID-19, who are not candidates for mechanical ventilation in the ICU. The investigators hypothesize that …
Sponsor: University of Calgary • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
Can a Pre-Surgery diet cut complications in esophageal cancer?
Disease control OngoingThis randomized controlled trial will evaluate the effects of preoperative enteral immunonutrition in esophageal cancer patients undergoing neoadjuvant therapy. The purpose of this study is to determine whether preoperative immune-modulating diet before surgery can improve the ra…
Phase 3 • Sponsor: Hecheng Li M.D., Ph.D • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Fish oil may protect babies of moms who smoke
Prevention CompletedSmoking is the most important modifiable risk factor for adverse pregnancy outcomes including preterm birth, neonatal death, and maternal complications. Rates of smoking cessation during pregnancy are low, particularly in underserved populations, and currently approved pharmacoth…
Phase 2 • Sponsor: Vanderbilt University Medical Center • Aim: Prevention
Last updated Jun 27, 2026 13:03 UTC
-
Super-Sized flu shot shows promise for seniors
Prevention CompletedPrimary Objective: Immunogenicity: To describe the immune response induced by high-dose quadrivalent influenza vaccine (QIV-HD) and AdimFlu-S (QIS) by hemagglutinin inhibition (HAI) measurement method in all participants. Safety: To describe the safety profile of all participan…
Phase 3 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: Prevention
Last updated Jun 27, 2026 07:51 UTC
-
Smart drain sensor could spot dangerous leaks after abdominal surgery
Diagnosis CompletedNERv's traditional feasibility clinical trial is a multi-center, pre-market, single-arm, and non-randomized trial. This study will involve the retrospective analysis of prospectively collected data. The trial is intended to establish the safety of NERv's Inline Device and collect…
Phase 2 • Sponsor: FluidAI Medical • Aim: Diagnosis
Last updated Jun 27, 2026 07:54 UTC
-
New hope for kids with resistant cancers? drug combo shows promise in early trial
Disease control CompletedThe study's purpose is to see if the drug, abemaciclib, is safe and effective when given with other drugs to kill cancer cells. The study is open to children and young adults with solid tumors, including neuroblastoma, that did not respond or grew during other anti-cancer treatme…
Phase 1/2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Can a glowing dye reveal hidden tooth decay?
Diagnosis CompletedThe aim of the study will be to make a comparison in vivo of the following techniques: DIAGNOcam, DIAGNOcam in combination with indocyanine and bitewing radiography, analyzing the ability to detect cavitation in initial proximal caries in posterior teeth using visual separation …
Sponsor: Universidad Rey Juan Carlos • Aim: Diagnosis
Last updated Aug 09, 2026 00:00 UTC
-
New eye drop aims to beat standard glaucoma treatment
Disease control CompletedThe objective of this clinical study is to evaluate the safety and efficacy of NCX 470 Ophthalmic Solution in lowering intraocular pressure (IOP) in subjecs with ocular hypertension or open-angle glaucoma. Subjects will be randomized in a 1:1 ratio to NCX 470 0.1% or to latanopro…
Phase 3 • Sponsor: Nicox Ophthalmics, Inc. • Aim: Disease control
Last updated Jun 26, 2026 15:05 UTC
-
Breathing new life into neck pain treatment?
Symptom relief CompletedThis study evaluates whether adding breathing exercises to standard physical therapy helps improve lung function and overall well-being in people with cervical discopathy (neck problems). Participants diagnosed with cervical discopathy will be divided into two groups. One group …
Sponsor: Medipol University • Aim: Symptom relief
Last updated Aug 22, 2026 00:00 UTC
-
Timing is everything: pre-pregnancy diet and exercise may slash diabetes risk
Prevention OngoingThe aim of this study is to investigate whether the combination of high intensity exercise and time restricted eating before and during pregnancy can reduce the risk of hyperglycaemia during pregnancy.
Sponsor: Norwegian University of Science and Technology • Aim: Prevention
Last updated Jun 27, 2026 12:05 UTC
-
Gene test may help men with prostate cancer skip treatment safely
Disease control OngoingThis study seeks to determine the clinical impact of Gene Expression Classifier (GEC) testing in prostate cancer care while also developing a pragmatic approach for improved GEC clinical use and future study.
Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Sep 09, 2026 15:00 UTC
-
Could AI and ultrasound replace unnecessary breast biopsies?
Diagnosis Recruiting nowThis clinical trial investigates the role of contrast enhanced ultrasound (CEUS) in identifying cystic breast masses as benign or malignant. Ultrasound is a diagnostic imaging test that uses sound waves to make pictures of the body without using radiation (x-rays). Ultrasounds ar…
Phase 1 • Sponsor: University of Southern California • Aim: Diagnosis
Last updated Jun 27, 2026 09:01 UTC
-
New antibody weapon targets stubborn blood cancers
Disease control OngoingAn open, multicenter, Phase I clinical study to evaluate the safety, tolerability, pharmacokinetics/pharmacokinetics, and antitumor activity of GNC-038 quad-specific antibody injection in relapsed or refractory non-Hodgkin's lymphoma, relapsed or refractory acute lymphoblastic le…
Phase 1 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New drug combo shows promise for Tough-to-Treat head and neck cancer
Disease control CompletedThe purpose of this study is to determine the best overall response of the combination of dostarlimab and niraparib in patients with recurrent and/or metastatic HNSCC patients.
Phase 2 • Sponsor: Trisha Wise-Draper • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New hope for wet AMD patients: a simple pill may drain stubborn eye fluid
Disease control Recruiting nowWet (or neovascular) form of age-related macular degeneration (wAMD) is the most common cause of blindness in the Western world. Currently, anti-vascular endothelial growth factor (VEGF) intravitreal injections (IVI) remain the standard-of-care treatment for wAMD. Previous studie…
Phase 2 • Sponsor: University of Iowa • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New balloon could save limbs in artery disease patients
Disease control OngoingThe SirPAD trial is an academic, investigator-initiated, single-center, randomized, non-inferiority, open-label clinical trial investigating whether the use of sirolimus-coated balloon catheters in patients with peripheral artery disease of the femoro-popliteal or below-the-knee …
Sponsor: Nils Kucher • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Heart burn: can zapping heart tissue stop deadly rhythms in brugada syndrome?
Disease control CompletedThis randomized, sham-controlled, and blinded clinical trial aims to evaluate the effects of radiofrequency catheter ablation on the phenotypic expression of patients with Brugada syndrome. The main questions it seeks to address are: * What are the immediate effects of radiofreq…
Sponsor: University of Sao Paulo General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC